title: OUTCOMES AFTER PARS PLANA VITRECTOMY FOR EPIRETINAL MEMBRANES ASSOCIATED WITH TOXOPLASMOSIS.
abstract: OBJECTIVE
  To evaluate outcomes and complications of pars plana vitrectomy in patients with epiretinal membrane secondary to toxoplasmic retinochoroiditis.
  
  
  METHODS
  Retrospective evaluation of the records of 14 patients who underwent pars plana vitrectomy for epiretinal membrane secondary to toxoplasmic retinochoroiditis. The best-corrected visual acuity, intraoperative and postoperative complications, and macular optical coherence tomography were analysed. All patients received postoperative prophylactic treatment with trimethoprim/sulfamethoxazole.
  
  
  RESULTS
  Fourteen patients, 5 men and 9 women, were included. Mean follow-up period after surgery was 6.07 ± 2.64 months. Preoperative mean best-corrected visual acuity was 20/200, and postoperative mean best-corrected visual acuity was 20/60. There were no intraoperative complications. Three patients developed posterior capsule opacification, and one patient developed cataract.
  
  
  CONCLUSIONS
  Pars plana vitrectomy is a safe and effective procedure in patients with epiretinal membrane secondary to toxoplasmic retinochoroiditis, improving both visual acuity and anatomical result on macular optical coherence tomography. The most frequent postoperative complications were posterior capsule opacification and cataract. No recurrences of the disease were recorded.
authors.affiliation: *Department of Ophthalmology and Visual Sciences, Paulista School of Medicine (EPM), Federal University of São Paulo (UNIFESP), São Paulo, Brazil; †Hospital Garcia de Orta, Almada, Portugal; and ‡Retina Clinic, São Paulo, Brazil.
authors.forename: Ana F
authors.initials: AF
authors.lastname: Miranda
authors.forename: Gabriel
authors.initials: G
authors.lastname: Costa de Andrade
authors.forename: Eduardo A
authors.initials: EA
authors.lastname: Novais
authors.forename: André
authors.initials: A
authors.lastname: Maia
authors.forename: Heloisa
authors.initials: H
authors.lastname: Nascimento
authors.forename: Cristina
authors.initials: C
authors.lastname: Muccioli
authors.forename: Rubens
authors.initials: R
authors.lastname: Belfort
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002825:Chorioretinitis / Q000000981:diagnostic imaging / Q000469:parasitology / Q000601:surgery*; D019773:Epiretinal Membrane / Q000000981:diagnostic imaging / Q000469:parasitology / Q000601:surgery*; D015822:Eye Infections, Parasitic / Q000000981:diagnostic imaging / Q000469:parasitology / Q000601:surgery*; D005260:Female; D006801:Humans; D007431:Intraoperative Complications; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012008:Recurrence; D012189:Retrospective Studies; D041623:Tomography, Optical Coherence; D014126:Toxoplasmosis, Ocular / Q000000981:diagnostic imaging / Q000469:parasitology / Q000601:surgery*; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination